Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...

Mobility, an autonomous vehicle (AV) technology company, announced an alliance relationship to bring new data and insight ...

Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

A young parolee brings unforeseen magic to a forlorn little town in “The Spitfire Grill,” running at Ross Valley Players through Feb. 23.

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...

Gilead Sciences Inc. must face a fired employee’s lawsuit alleging its response to a co-worker’s false sexual harassment ...

The 24th Mount Gilead Athletic Hall of Fame induction ceremony took place on Friday, Jan. 17. There was a reception at 6 p.m. in the high school Community Room, and the ceremony took place in between ...

Last week, during their monthly town board meeting, Mt. Gilead commissioners approved the adoption of an ordinance allowing a social district for the downtown historical district. The matter had been ...

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of ...